FI885358A - Förfarande för framställning av en injekterbar melfalansammansättning - Google Patents

Förfarande för framställning av en injekterbar melfalansammansättning Download PDF

Info

Publication number
FI885358A
FI885358A FI885358A FI885358A FI885358A FI 885358 A FI885358 A FI 885358A FI 885358 A FI885358 A FI 885358A FI 885358 A FI885358 A FI 885358A FI 885358 A FI885358 A FI 885358A
Authority
FI
Finland
Prior art keywords
producing
melphalan
melphalan composition
hydrochloride
substantially pure
Prior art date
Application number
FI885358A
Other languages
English (en)
Finnish (fi)
Other versions
FI885358A0 (sv
FI90204C (sv
FI90204B (sv
Inventor
Stephen William Poole
Timothy Paul Stanley
Geoffrey Divall
Terence William Packham
Joseph Knight
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI885358A0 publication Critical patent/FI885358A0/sv
Publication of FI885358A publication Critical patent/FI885358A/sv
Priority to FI924668A priority Critical patent/FI102275B/sv
Application granted granted Critical
Publication of FI90204B publication Critical patent/FI90204B/sv
Publication of FI90204C publication Critical patent/FI90204C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
FI885358A 1987-11-19 1988-11-18 Förfarande för framställning av en injekterbar melfalansammansättning FI90204C (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI924668A FI102275B (sv) 1987-11-19 1992-10-15 Förfarande för framställning av väsentligen ren melfalanhydroklorid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878727157A GB8727157D0 (en) 1987-11-19 1987-11-19 Pharmaceutical formulations
GB8727157 1987-11-19

Publications (4)

Publication Number Publication Date
FI885358A0 FI885358A0 (sv) 1988-11-18
FI885358A true FI885358A (sv) 1989-05-20
FI90204B FI90204B (sv) 1993-09-30
FI90204C FI90204C (sv) 1994-01-10

Family

ID=10627252

Family Applications (2)

Application Number Title Priority Date Filing Date
FI885358A FI90204C (sv) 1987-11-19 1988-11-18 Förfarande för framställning av en injekterbar melfalansammansättning
FI924668A FI102275B (sv) 1987-11-19 1992-10-15 Förfarande för framställning av väsentligen ren melfalanhydroklorid

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI924668A FI102275B (sv) 1987-11-19 1992-10-15 Förfarande för framställning av väsentligen ren melfalanhydroklorid

Country Status (22)

Country Link
US (1) US4997651A (sv)
EP (1) EP0317281B1 (sv)
JP (1) JP2693191B2 (sv)
KR (1) KR970002607B1 (sv)
AT (1) ATE83922T1 (sv)
AU (1) AU619781B2 (sv)
CA (1) CA1341114C (sv)
DE (1) DE3877151T2 (sv)
DK (1) DK172794B1 (sv)
ES (1) ES2052745T3 (sv)
FI (2) FI90204C (sv)
GB (1) GB8727157D0 (sv)
GR (1) GR3007287T3 (sv)
HK (1) HK108994A (sv)
HU (3) HU206671B (sv)
IE (1) IE63996B1 (sv)
IL (1) IL88419A (sv)
LV (1) LV10179B (sv)
NZ (2) NZ239867A (sv)
PT (1) PT89028B (sv)
SG (1) SG73894G (sv)
ZA (1) ZA888674B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695751A (en) * 1993-04-08 1997-12-09 Cornell Research Foundation, Inc. Enhancing delivery of large neutral amino acid drugs
US5407672A (en) * 1993-04-08 1995-04-18 Cornell Research Foundation, Inc. Enhancing the anti-tumor effect of melphalan with L-amino acid oxidase
US6020004A (en) * 1997-04-17 2000-02-01 Amgen Inc. Biodegradable microparticles for the sustained delivery of therapeutic drugs
US5980904A (en) * 1998-11-18 1999-11-09 Amway Corporation Skin whitening composition containing bearberry extract and a reducing agent
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
WO2004000229A2 (en) * 2002-06-24 2003-12-31 Research Development Foundation Treatment of human multiple myeloma by curcumin
WO2006046934A2 (en) 2003-08-26 2006-05-04 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
US8501818B2 (en) 2005-03-14 2013-08-06 Ceptaris Therapeutics, Inc. Stabilized compositions of alkylating agents and methods of using same
US7872050B2 (en) 2005-03-14 2011-01-18 Yaupon Therapeutics Inc. Stabilized compositions of volatile alkylating agents and methods of using thereof
ES2848841T3 (es) 2008-03-27 2021-08-12 Helsinn Healthcare Sa Composiciones estabilizadas de agentes de alquilación y métodos de utilización de estas composiciones
AR066943A1 (es) * 2008-06-10 2009-09-23 Eriochem Sa Una composicion farmaceutica de melfalano
US20100311838A1 (en) 2009-05-29 2010-12-09 Pipkin James D Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
AR077384A1 (es) 2010-07-05 2011-08-24 Eriochem Sa Una formulacion farmaceutica inyectable de melfalano.
US8921596B2 (en) * 2010-11-04 2014-12-30 Emcure Pharmaceuticals, Ltd. Process for the preparation of melphalan hydrochloride
EP2701720B1 (en) 2011-04-28 2017-07-12 Oncopeptides AB Lyophilized preparation of cytotoxic dipeptides
WO2014065751A1 (en) 2012-10-26 2014-05-01 Oncopeptides Ab Lyophilized preparations of melphalan flufenamide
WO2014141294A2 (en) 2013-03-11 2014-09-18 Biophore India Pharmaceuticals Pvt. Ltd. An improved process for the synthesis of melphalan and the hydrochloride salt
ITMI20130896A1 (it) * 2013-05-31 2014-12-01 Farmabios Spa Processo di purificazione di melphalan
HUE042681T2 (hu) * 2015-03-06 2019-07-29 Leadiant Biosciences Sa In Liquidazione Myeloma multiplex roneparstat kombinációs terápiája
US10537520B2 (en) * 2015-06-30 2020-01-21 Leiutis Pharmaceuticals Pvt. Ltd. Stable liquid formulations of melphalan
KR20200136997A (ko) * 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형
US10682326B1 (en) 2019-06-03 2020-06-16 Shilpa Medicare Limited Stable melphalan liquid injectable formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB750155A (en) * 1953-03-17 1956-06-13 Nat Res Dev Substituted alanines
US3032585A (en) * 1954-12-03 1962-05-01 Nat Res Dev Process for the production of p-bis-(2-chloroethyl)-aminophenylalanine
DE1292660B (de) * 1963-04-24 1969-04-17 Ural Polytechnitscheskij I Im Verfahren zur Herstellung von p-(Bis-ª‰-chloraethyl-amino)-phenylalanin-hydrochlorid
US4029778A (en) * 1969-01-23 1977-06-14 Aktiebolaget Leo Cortical steroid nitrogen mustard compositions and treatment therewith
RO57195A2 (sv) * 1970-11-30 1974-09-01
FR2285855A1 (fr) * 1974-09-25 1976-04-23 Kohjin Co Composition therapeutique lyophilisee a base de sel de cyclocytidine et son procede de preparation
JPS59186924A (ja) * 1983-04-08 1984-10-23 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤
US4696814A (en) * 1985-08-21 1987-09-29 Warner-Lambert Company Parenteral phenytoin compositions
JPS62192357A (ja) * 1986-02-19 1987-08-22 Kureha Chem Ind Co Ltd Ｎ−フタロイル−ｐ−ニトロ−Ｌ−フエニルアラニンの製造方法

Also Published As

Publication number Publication date
AU619781B2 (en) 1992-02-06
AU2574888A (en) 1989-05-25
KR890007729A (ko) 1989-07-05
HK108994A (en) 1994-10-14
HU9100335D0 (en) 1991-08-28
IL88419A0 (en) 1989-06-30
JPH01153628A (ja) 1989-06-15
JP2693191B2 (ja) 1997-12-24
LV10179B (en) 1995-06-20
NZ239867A (en) 1992-11-25
EP0317281A3 (en) 1989-08-09
FI924668A0 (fi) 1992-10-15
DK646688A (da) 1989-05-20
KR970002607B1 (ko) 1997-03-06
IE63996B1 (en) 1995-06-28
GR3007287T3 (sv) 1993-07-30
HU910336D0 (en) 1991-08-28
HU207286B (en) 1993-03-29
FI885358A0 (sv) 1988-11-18
HUT48198A (en) 1989-05-29
SG73894G (en) 1994-11-25
HU206671B (en) 1992-12-28
ZA888674B (en) 1990-07-25
FI102275B1 (sv) 1998-11-13
FI90204C (sv) 1994-01-10
IE883447L (en) 1989-05-19
FI90204B (sv) 1993-09-30
CA1341114C (en) 2000-10-10
FI924668A (fi) 1992-10-15
IL88419A (en) 1993-03-15
EP0317281B1 (en) 1992-12-30
LV10179A (lv) 1994-10-20
PT89028A (pt) 1988-12-01
ES2052745T3 (es) 1994-07-16
HU203197B (en) 1991-06-28
GB8727157D0 (en) 1987-12-23
DE3877151T2 (de) 1993-07-15
FI102275B (sv) 1998-11-13
US4997651A (en) 1991-03-05
DK646688D0 (da) 1988-11-18
EP0317281A2 (en) 1989-05-24
PT89028B (pt) 1993-02-26
DK172794B1 (da) 1999-07-19
DE3877151D1 (de) 1993-02-11
NZ227004A (en) 1992-11-25
ATE83922T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
FI885358A (sv) Förfarande för framställning av en injekterbar melfalansammansättning
ATE82495T1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
BG44538A3 (en) Method for preparing salts of 5- metoxy- 2- big bracket [(4- metoxy- 3, 5- dimethyl- 2- pyridinyl)- methyl] sulphonyl- 1h- benzimidazol
IT8747630A0 (it) Derivati di dicloroanilina, composizioni farmaceutiche che li contengono e procedimento per produrli
ATE121949T1 (de) 5,10-methylentetrahydrofolsäure-cyclodextrin- einschlussverbindungen.
HUT46224A (en) Process for producing pharmaceutical compositions containing prostaglandin e1-derivatives
HUT49630A (en) Process for producing new cyclic amino acid derivatives and pharmaceutical compositions comprising same
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
DE3577443D1 (de) Derivate von dihydroorotsaeure, deren verfahren zur herstellung und deren pharmazeutische zusammensetzungen.
MY105860A (en) Pharmaceutical formulations.
ATA347677A (de) Verfahren zur herstellung von pharmazeutischen praeparaten zur oralen verabreichung
GB2001995A (en) An immunostimulant, a process for preparing it, and compositions containing it
DK435384D0 (da) L-argininisoxicamat
ATA95580A (de) Verfahren zur herstellung von antihypertensiven pharmazeutischen zubereitungen
HUT54659A (en) Process for producing new cyclic anthranilacetic acid derivatives, their salts formed with acids and bases, as well as pharmaceutical compositions comprising same as active ingredient
AT340581B (de) Verfahren zur herstellung von pharmazeutischen praparaten mit synergistischer, analgetischer wirkung

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: THE WELLCOME FOUNDATION LIMITED

MA Patent expired